T. Rowe Price Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $38.9M | Sell |
|
|||||
|
2022
Q2 | $99.3M | Sell |
|
|||||
|
2022
Q1 | $110M | Sell |
|
|||||
|
2021
Q4 | $95.4M | Sell |
|
|||||
|
2021
Q3 | $86.8M | Sell |
|
|||||
|
2021
Q2 | $132M | Sell |
|
|||||
|
2021
Q1 | $158M | Sell |
|
|||||
|
2020
Q4 | $176M | Sell |
|
|||||
|
2020
Q3 | $232M | Sell |
|
|||||
|
2020
Q2 | $288M | Sell |
|
|||||
|
2020
Q1 | $258M | Sell |
|
|||||
|
2019
Q4 | $450M | Buy |
|
|||||
|
2019
Q3 | $222M | Buy |
|
|||||
|
2019
Q2 | $220M | Buy |
|
|||||
|
2019
Q1 | $191M | Buy |
|
|||||
|
2018
Q4 | $129M | Buy |
|
|||||
|
2018
Q3 | $114M | Buy |
|
|||||
|
2018
Q2 | $124M | Buy |
|
|||||
|
2018
Q1 | $122M | Buy |
|
|||||
|
2017
Q4 | $76M | Buy |
|
|||||
|
2017
Q3 | $20.7M | Buy |
|
|||||
|
2017
Q2 | $15.2M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $4.95M | Buy |
|